RIGEL PHARMACEUTICALS INC - Common Stock (RIGL)
CUSIP: 766559702
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 18,187,050
- Total 13F shares
- 13,902,025
- Share change
- +1,742,118
- Total reported value
- $250,095,419
- Put/Call ratio
- 63%
- Price per share
- $17.99
- Number of holders
- 118
- Value change
- +$32,047,743
- Number of buys
- 61
- Number of sells
- 56
Quarterly Holders Quick Answers
What is CUSIP 766559702?
CUSIP 766559702 identifies RIGL - RIGEL PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 766559702:
Top shareholders of RIGL - RIGEL PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.7%
from 13D/G
|
1,748,107
|
$29,403,160 | — | 31 Dec 2024 | |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
8.5%
|
1,516,000
|
$28,894,960 | +$6,937,840 | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
8.6%
|
1,561,496
|
$26,264,362 | — | 31 Dec 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
6.2%
|
1,130,679
|
$19,018,021 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.6%
|
1,012,931
|
$17,037,500 | — | 31 Dec 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.3%
|
410,778
|
$6,909,286 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
402,051
|
$6,764,329 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
380,515
|
$6,400,262 | — | 31 Dec 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
2.1%
|
376,366
|
$6,329,000 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.6%
|
299,709
|
$5,041,105 | — | 31 Dec 2024 | |
| CM Management, LLC |
13F
|
Company |
1.3%
|
242,500
|
$4,078,850 | — | 31 Dec 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.1%
|
202,089
|
$3,399,137 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.99%
|
180,492
|
$3,035,876 | — | 31 Dec 2024 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
0.94%
|
170,100
|
$2,861,082 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.92%
|
166,935
|
$2,807,846 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.8%
|
145,839
|
$2,453,012 | — | 31 Dec 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.76%
|
139,128
|
$2,340,133 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
0.71%
|
129,506
|
$2,178,291 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.65%
|
117,957
|
$1,984,037 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.6%
|
108,587
|
$1,826,433 | — | 31 Dec 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.47%
|
86,001
|
$1,446,537 | — | 31 Dec 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.47%
|
85,878
|
$1,444,468 | — | 31 Dec 2024 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.47%
|
85,423
|
$1,436,815 | — | 31 Dec 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.46%
|
84,311
|
$1,418,111 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.43%
|
77,407
|
$1,301,986 | — | 31 Dec 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.4%
|
72,451
|
$1,218,626 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.39%
|
70,426
|
$1,184,565 | — | 31 Dec 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.37%
|
68,191
|
$1,146,000 | — | 31 Dec 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.35%
|
63,416
|
$1,066,657 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.35%
|
63,128
|
$1,061,813 | — | 31 Dec 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
62,870
|
$1,057,473 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.34%
|
62,528
|
$1,051,721 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.33%
|
60,913
|
$1,024,557 | — | 31 Dec 2024 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.29%
|
52,295
|
$879,602 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
50,195
|
$844,281 | — | 31 Dec 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.24%
|
44,171
|
$742,956 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.22%
|
40,577
|
$682,505 | — | 31 Dec 2024 | |
| Universal- Beteiligungs- und Servicegesellschaft mbH |
13F
|
Individual |
0.22%
|
40,200
|
$676,164 | — | 31 Dec 2024 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.2%
|
36,259
|
$609,876 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.19%
|
34,983
|
$588,414 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.18%
|
32,166
|
$541,032 | — | 31 Dec 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.17%
|
31,473
|
$529,376 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.17%
|
31,336
|
$527,073 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.17%
|
30,901
|
$519,755 | — | 31 Dec 2024 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.17%
|
30,840
|
$518,000 | — | 31 Dec 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.17%
|
30,035
|
$505,189 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.16%
|
28,411
|
$477,873 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.14%
|
25,143
|
$422,891 | — | 31 Dec 2024 | |
| STRS OHIO |
13F
|
Company |
0.14%
|
24,600
|
$413,772 | — | 31 Dec 2024 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0.13%
|
23,700
|
$398,634 | — | 31 Dec 2024 |
Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) as of Q1 2025
As of 31 Mar 2025,
RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,902,025 shares.
The largest 10 holders included
BlackRock, Inc., MORGAN STANLEY, ARMISTICE CAPITAL, LLC, Soleus Capital Management, L.P., VANGUARD GROUP INC, Capitolis Liquid Global Markets LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, Assenagon Asset Management S.A., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
118
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
114
Q1 2025 holders
118
Holder diff
4
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.